Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach

Abstract

The most commonly used oral drug in treating type 2 diabetes (T2DM) after metformin are sufonylureas (SUs) based on the confidence gained over the several decades and because of its cheaper cost. Unfortunately, SUs are associated with secondary failure and sometimes associated with therapy related severe hypoglycaemia limiting its compliance and wider… (More)
DOI: 10.4103/2230-8210.139214

Topics

11 Figures and Tables

Cite this paper

@inproceedings{Singh2014DecidingOD, title={Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach}, author={Awadhesh Kumar Singh}, booktitle={Indian journal of endocrinology and metabolism}, year={2014} }